Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor

Nucleic Acids Research

Volumn 34, Issue 2, 2006, Pages 543-554

  Saramäki, Anna ^a   Banwell, Claire M ^a,b   Campbell, Moray J ^b   Carlberg, Carsten ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; COLECALCIFEROL RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; FLUOROURACIL; PROTEIN ANTIBODY; PROTEIN P53; RECEPTOR ANTIBODY; RECOMBINANT PROTEIN; STEROID RECEPTOR COACTIVATOR 1; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ASSOCIATED PROTEIN 220; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; BINDING SITE; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; COMPUTER MODEL; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE CONTROL; GENE FUNCTION; GENE LOCATION; GENETIC SCREENING; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROCESS MONITORING; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RECEPTOR OCCUPANCY; RNA TRANSLATION;

BINDING SITES; CALCITRIOL; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FLUOROURACIL; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, CALCITRIOL; RESPONSE ELEMENTS; RETINOID X RECEPTORS; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

MINK CELL FOCUS-FORMING VIRUS;

EID: 32644451972     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkj460     Document Type: Article

References (34)

1. Sutton,A.L. and MacDonald,P.N. (2003) Vitamin D: More than a 'bone-a-fide' hormone. Mol. Endocrinol., 17, 777-791.
2. 3 and its analogs on growth control and tumorigenesis. Front. Biosci., 6, D820-D848.
3. Jiang,H., Lin,J., Su,Z.-Z., Collart,F.R., Huberman,E. and Fisher,P.B. (1994) Induction of differentiation in human promyelotic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9, 3397-3406.
4. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev., 10, 142-153.
5. Espinosa,J.M. and Emerson,B.M. (2001) Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell, 8, 57-69.
6. Lowe,S.W., Ruley,H.E., Jacks,T. and Housman,D.E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
7. 3. Crit. Rev. Eukaryot. Gene. Expr, 8, 19-42.
8. 3 receptor in the context of the nuclear receptor superfamily: The central role of retinoid X receptor. Endocrine, 4, 91-105.
9. Quack,M. and Carlberg,C. (2000) Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. J. Mol. Biol., 296, 743-756.
10. 3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Oncogene, 11, 1853-1858.
11. Tokino,T., Thiagalingam,S., el-Deiry,W.S., Waldman,T., Kinzler,K.W. and Vogelstein,B. (1994) p53 tagged sites from human genomic DNA. Hum. Mol. Genet., 3, 1537-1542.
12. el-Deiry,W.S., Kern,S.E., Pietenpol,J.A., Kinzler,K.W. and Vogelstein,B. (1992) Definition of a consensus binding site for p53. Nature Genet., 1, 45-49.
13. 3. J. Mol. Biol., 350, 65-77.
14. 3-responsive regions in its promoter. Nucleic Acids Res., 33, 2440-2451.
15. 3. Nucleic Acids Res., 33, 5521-5532.
16. CIP1 expression in normal and neoplastic tissues. Cancer Res., 55.
17. Krishnan,A.V., Shinghal,R., Raghavachari,N., Brooks,J.D., Peehl,D.M. and Feldman,D. (2004) Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Prostate, 59, 243-251.
18. Leo,C. and Chen,J.D. (2000) The SRC family of nuclear receptor coactivators. Gene, 245, 1-11.
19. Kwok,R.P.S., Lundblad,J.R., Chrivia,J.C., Richards,J.P., Bächinger,H.P., Brennan,R.G., Roberts,S.G.E., Green,M.R. and Goodman,R.H. (1994) Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature, 370, 223-226.
20. Castillo,A.I., Jimenez-Lara,A.M., Tolon,R.M. and Aranda,A. (1999) Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: Role of coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Mol. Endocrinol., 13, 1141-1154.
21. 3 receptor in a ligand-dependent manner and enhances transactivation in a cell-free system. Genes Dev., 12, 1787-1800.
22. Rachez,C., Lemon,B.D., Suldan,Z., Bromleigh,V., Gamble,M., Näär,A.M., Erdjument-Bromage,H., Tempst,P. and Freedman,L.P. (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature, 398, 824-828.
23. Toell,A., Polly,P. and Carlberg,C. (2000) All natural DR3-type vitamin D response elements show a similar functionality in vitro. Biochem. J., 352, 301-309.
24. 3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol. Cell. Endocrinol., 142, 57-65.
25. 3 growth inhibition in the LNCaP prostate cancer cell line through p21/ WAF1. J. Urol., 165, 1319-1324.
26. Carlberg,C., Bendik,I., Wyss,A., Meier,E., Sturzenbecker,L.J., Grippo,J.F. and Hunziker,W. (1993) Two nuclear signalling pathways for vitamin D. Nature, 361, 657-660.
27. Levin,A.A., Sturzenbecker,L.J., Kazmer,S., Bosakowski,T., Huselton,C., Allenby,G., Speck,J., Kratzeisen,C., Rosenberger,M., Lovey,A. et al. (1992) 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature, 355, 359-361.
28. 3 receptor binding site found in the rat atrial natriuretic factor promoter. Biochem. Biophys. Res. Commun., 218, 882-886.
29. Jurka,J., Klonowski,P., Dagman,V. and Pelton,P. (1996) CENSOR: A program for identification and elimination of repetitive elements from DNA sequences. Comput. Chem., 20, 119-121.
30. Kaeser,M.D. and Iggo,R.D. (2004) Promoter-specific p53-dependent histone acetylation following DNA damage. Oncogene, 23, 4007-4013.
31. Vogelstein,B., Lane,D. and Levine,A.J. (2000) Surfing the p53 network. Nature, 408, 307-310.
32. Kaeser,M.D. and Iggo,R.D. (2002) Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl Acad. Sci. USA, 99, 95-100.
33. Vousden,K.H. and Lu,X. (2002) Live or let die: The cell's response to p53. Nature Rev. Cancer, 2, 594-604.
34. 3 and its nuclear receptor. J. Mol. Biol., 349, 248-260.